CUHK_CCT00156
2008-02-15
Prospective
Not applicable
N/A
Nil
Nil
Miss Joyce Kung
3/F, Hong Kong Eye Hospital, 147K Argyle Street, Kowloon
27623134
joycekung@cuhk.edu.hk
Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong
Prof. Dennis SC Lam
3/F, Hong Kong Eye Hospital, 147K Argyle Street, Kowloon.
27623134
dennislam_cu_res@cuhk.edu.hk
Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong
Intravitreal injection of Bevacizumab (Avastin®) as an adjunctive therapy of pterygium surgery to prevent recurrence: A pilot study
Intravitreal injection of Bevacizumab (Avastin®) as an adjunctive therapy of pterygium surgery to prevent recurrence: A pilot study
Not applicable
Hong Kong
Yes
2008-01-31
pterygium
Procedure
Intravitreal injection of Bevacizumab (Avastin®) after surgical excision of pterygium
one injection immediately after surgical excision of pterygium
There is no comparative treatment as this is a pilot study. We will observe the recurrence rate of pterygium being treated with adjunctive intravitreal Avastin injection and design a randomized controlled trial in the future.
Inclusion criteria: 1. Age 18 years or above 2. Eye with single-head primary or secondary pterygium 3. Patient able and willing to give informed consent to the pterygium surgery with intravitreal injections of bevacizumab
Exclusion criteria: 1. Single functional eye 2. Pregnant patients 3. Use of anticoagulants or antiplatelet therapy other than aspirin / NSAID within 14 days of surgery.
18
None set
Both Male and Female
Interventional
Non-randomized
Uncontrolled
Open label
Single group
2008-03-01
50 eyes
Complete
Recurrence of pterygium, up to 24 months post op
- Visual acuity (VA) - Intraocular pressure (IOP) - Corneal endothelial cell counts - Corneal astigmatism - Any complications from the injections
2013-01-14
ChiCTR-ONC-08000714
2010-05-04
|
|
|
|
---|---|---|---|
No documents yet. |